MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris.
- DOI
- 10.1016/j.ymthe.2026.10.034
- Published
- 2026 Nov 6
- Container
- Molecular therapy : the journal of the American Society of Gene Therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2026.10.034,
title = {MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris.},
author = {Emtenani S and Patzelt S and Zarabadi K and Yang T and Sigmund AM and Hofrichter M and Probst C and Waschke J and Schmidt E},
year = {2026},
journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
doi = {10.1016/j.ymthe.2026.10.034},
url = {https://doi.org/10.1016/j.ymthe.2026.10.034}
}RIS
TY - JOUR TI - MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris. AU - Emtenani S AU - Patzelt S AU - Zarabadi K AU - Yang T AU - Sigmund AM AU - Hofrichter M AU - Probst C AU - Waschke J AU - Schmidt E PY - 2026 JO - Molecular therapy : the journal of the American Society of Gene Therapy DO - 10.1016/j.ymthe.2026.10.034 UR - https://doi.org/10.1016/j.ymthe.2026.10.034 ER -
APA
S, E., S, P., K, Z., T, Y., AM, S., M, H., C, P., J, W., & E, S. (2026). MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.10.034
Source records
- pubmed · retrieved 2026-11-10T09:57:34.929Z